Canadian Respiratory Journal · 2014 · 15 citations · 28 references
MedicineClinical SciencesClinical Classification SystemsClinical EpidemiologyPulmonologyClinical Outcome AssessmentDiagnostic EvaluationDiagnostic Test EvaluationPulmonary AssessmentPulmonary EmbolismClinical Score EvaluationCritical Care ThromboprophylaxisPretest MeasurementPretest Risk EstimationPulmonary Embolism Risk StratificationRisk Prediction ScoresThromboprophylaxis In Critical IllnessVenous Thromboembolism Diagnosis
BACKGROUND: Prediction scores for pretest probability of pulmonary embolism (PE) validated in outpatient settings are occasionally used in the intensive care unit (ICU). OBJECTIVE: To evaluate the correlation of Geneva and Wells scores with adjudicated categories of PE in ICU patients. METHODS: In a randomized trial of thromboprophylaxis, patients with suspected PE were adjudicated as possible, probable or definite PE. Data were then retrospectively abstracted for the Geneva Diagnostic PE score, Wells, Modified Wells and Simplified Wells Diagnostic scores. The chance-corrected agreement between adjudicated categories and each score was calculated. ANOVA was used to compare values across the three adjudicated PE categories. RESULTS: Among 70 patients with suspected PE, agreement was poor between adjudicated categories and Geneva pretest probabilities (kappa=0.01 [95% CI -0.0643 to 0.0941]) or Wells pretest probabilities (kappa=-0.03 [95% CI -0.1462 to 0.0914]). Among four possible, 16 probable and 50 definite PEs, there were no significant differences in Geneva scores (possible = 4.0, probable = 4.7, definite = 4.5; P=0.90), Wells scores (possible = 2.8, probable = 4.9, definite = 4.1; P=0.37), Modified Wells (possible = 2.0, probable = 3.4, definite = 2.9; P=0.34) or Simplified Wells (possible = 1.8, probable = 2.8, definite = 2.4; P=0.30). CONCLUSIONS: Pretest probability scores developed outside the ICU do not correlate with adjudicated PE categories in critically ill patients. Research is needed to develop prediction scores for this population.
28
ANTICOAGULANT DRUGS IN THE TREATMENT OF PULMONARY EMBOLISM
D W Barritt, S.C. Jordan · The Lancet · 1960 · 1.4K citations
Value of assessment of pretest probability of deep-vein thrombosis in clinical management
Philip S. Wells, David R. Anderson, Janis Bormanis et al. · The Lancet · 1997 · 1.2K citations